| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.58B | 69.25B | 64.44B | 58.23B | 52.89B | 49.89B |
| Gross Profit | 13.45B | 14.91B | 12.96B | 10.97B | 9.33B | 8.81B |
| EBITDA | 5.18B | 5.80B | 4.86B | 4.26B | 3.36B | 4.64B |
| Net Income | 3.26B | 3.69B | 3.10B | 2.73B | 1.94B | 2.82B |
Balance Sheet | ||||||
| Total Assets | 45.64B | 53.14B | 48.57B | 42.95B | 37.56B | 35.14B |
| Cash, Cash Equivalents and Short-Term Investments | 10.64B | 8.20B | 9.00B | 6.99B | 6.58B | 7.25B |
| Total Debt | 3.60B | 3.20B | 3.65B | 1.73B | 1.02B | 887.00M |
| Total Liabilities | 19.43B | 22.20B | 22.44B | 18.73B | 15.85B | 14.65B |
| Stockholders Equity | 26.01B | 30.74B | 25.93B | 24.04B | 21.54B | 20.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.32B | 1.64B | 762.00M | 368.00M | 1.49B |
| Operating Cash Flow | 0.00 | 2.76B | 4.96B | 2.42B | 921.00M | 1.78B |
| Investing Cash Flow | 0.00 | -1.54B | -3.47B | -1.80B | -697.00M | 971.00M |
| Financing Cash Flow | 0.00 | -2.08B | 378.00M | -287.00M | -1.02B | -2.37B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥37.25B | 18.17 | 10.19% | 3.21% | 11.55% | -2.44% | |
75 Outperform | ¥281.02B | 40.18 | ― | 0.87% | 16.66% | 32.19% | |
72 Outperform | ¥53.96B | 14.42 | ― | 3.33% | 7.46% | 18.73% | |
71 Outperform | ¥275.20B | 13.08 | 30.73% | 2.20% | 5.71% | -51.99% | |
71 Outperform | ¥10.00B | 10.70 | ― | 1.08% | 24.66% | 146.85% | |
69 Neutral | ¥21.55B | 15.29 | ― | 1.34% | 16.49% | 24.80% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |